Improving quality of life in patients with metastatic prostate cancer following one cycle of 177Lu-PSMA-617 radioligand therapy: a pilot study.
Nuklearmedizin. Nuclear medicine
View this publicationNuklearmedizin. Nuclear medicine
View this publicationAntioxidants & redox signaling
View this publicationZentralblatt fur Chirurgie
View this publicationFood chemistry
View this publicationMetabolites
View this publicationVaccine
View this publicationJAMA
View this publicationAlzheimer's & dementia : the journal of the Alzheimer's Association
View this publicationImmunology
View this publicationPLoS neglected tropical diseases
View this publication